ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,144 | -99.9% | 54,901 | -10.1% | 0.00% | 0.0% |
| Q2 2022 | $861,000 | +164.1% | 61,099 | +901.6% | 0.00% | – |
| Q4 2020 | $326,000 | -94.5% | 6,100 | -95.8% | 0.00% | -100.0% |
| Q3 2020 | $5,930,000 | -57.2% | 143,761 | -49.8% | 0.01% | -65.4% |
| Q2 2020 | $13,869,000 | +894.9% | 286,134 | +767.1% | 0.03% | +550.0% |
| Q1 2020 | $1,394,000 | -95.0% | 33,000 | -94.9% | 0.00% | -93.8% |
| Q4 2019 | $27,689,000 | – | 647,248 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |